Dearen Danny L. 4

What Happened
Danny L. Dearen, a director of Beta Bionics, was granted 16,965 restricted stock units (RSUs) on May 21, 2026. The Form 4 lists the transaction as an acquisition/award (code A) at $0.00 per share (reported value $0). This was a compensation grant under the company’s equity plan, not an open-market purchase or a sale.

Key Details

• Transaction date: 2026-05-21; Form 4 filed: 2026-05-26 (filed timely; filing falls within two business days after the transaction given the Memorial Day holiday).
• Transaction type/code: A = Award/Grant — 16,965 RSUs @ $0.00.
• Shares owned after transaction: Not reported in this filing.
• Footnote: F1 — Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
• No immediate sale, exercise, tax-withholding sale, or 10b5-1 plan noted in the reported transaction.

Context
RSUs are a promise to deliver shares if and when vesting conditions are met; they generally vest over time or upon milestones and do not reflect an immediate cash investment by the insider. Grants are common compensation for executives and directors and do not by themselves signal insiders buying or selling in the market.